BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 10220691)

  • 1. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy.
    Nigro JJ; DeMeester SR; Hagen JA; DeMeester TR; Peters JH; Kiyabu M; Campos GM; Oberg S; Gastal O; Crookes PF; Bremner CG
    J Thorac Cardiovasc Surg; 1999 May; 117(5):960-8. PubMed ID: 10220691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
    Shim YM; Park JS; Lee M; Kim D; Kim K
    Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma.
    Clark GW; Peters JH; Ireland AP; Ehsan A; Hagen JA; Kiyabu MT; Bremner CG; DeMeester TR
    Ann Thorac Surg; 1994 Sep; 58(3):646-53; discussion 653-4. PubMed ID: 7944684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.
    Hagen JA; Peters JH; DeMeester TR
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):850-8; discussion 858-9. PubMed ID: 8231207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies.
    Hagen JA; DeMeester SR; Peters JH; Chandrasoma P; DeMeester TR
    Ann Surg; 2001 Oct; 234(4):520-30; discussion 530-1. PubMed ID: 11573045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus.
    Johansson J; DeMeester TR; Hagen JA; DeMeester SR; Peters JH; Oberg S; Bremner CG
    Arch Surg; 2004 Jun; 139(6):627-31; discussion 631-3. PubMed ID: 15197089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy.
    Nigro JJ; Hagen JA; DeMeester TR; DeMeester SR; Peters JH; Oberg S; Theisen J; Kiyabu M; Crookes PF; Bremner CG
    J Thorac Cardiovasc Surg; 1999 Jan; 117(1):16-23; discussion 23-5. PubMed ID: 9869753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
    Jang HJ; Lee HS; Kim MS; Lee JM; Zo JI
    Ann Thorac Surg; 2011 Sep; 92(3):1091-7. PubMed ID: 21704967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
    Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
    Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.
    Altorki N; Kent M; Ferrara C; Port J
    Ann Surg; 2002 Aug; 236(2):177-83. PubMed ID: 12170022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
    Lagarde SM; Phillips AW; Navidi M; Disep B; Griffin SM
    Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
    Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
    Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
    Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy.
    Li H; Zhang Y; Cai H; Xiang J
    Eur Surg Res; 2007; 39(1):1-6. PubMed ID: 17106199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome with Primary En-bloc Esophagectomy for Submucosal Esophageal Adenocarcinoma.
    Schwameis K; Green KM; Worrell SG; Samaan J; Cooper S; Tatishchev S; Oh DS; Hagen JA; DeMeester SR
    Ann Surg Oncol; 2017 Dec; 24(13):3921-3925. PubMed ID: 28975518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of lymph node removal during esophageal cancer surgery and survival.
    van der Schaaf M; Johar A; Wijnhoven B; Lagergren P; Lagergren J
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25748792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.
    Dubecz A; Kern M; Solymosi N; Schweigert M; Stein HJ
    Ann Thorac Surg; 2015 Jun; 99(6):1879-85; discussion 1886. PubMed ID: 25929888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.